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Abstract 
Extended-spectrum beta-lactamases (ESBLs) are plasmid-mediated enzymes commonly found in the 
Enterobacteriaceae that are capable of hydrolysing ß-lactams except carbapenems and cephamycins. ESBLs also 
confer resistance to several non-ß-lactam antibiotics. ESBL producing isolates are predominantly Klebsiella 
pneumoniae and Eschericia coli. Klebsiella pneumoniae are one of the most common causes of urinary tract 
infections such as cystitis and pyelonephritis developed by about 150 million people in every given year. ESBL-
producing Klebsiella pneumoniae appear susceptible to cephalosporins in vitro using conventional breakpoints but 
ineffective in vivo. This has limited treatment options for urinary tract infections caused by extended-spectrum 
beta-lactamases -producing K. pneumoniae. This study determined the in vitro efficacy of Psidium guajava on 
extended-spectrum beta-lactamases -producing K. pneumoniae using agar well diffusion and well microplate 
dilution method. Serial dilutions of the ethanolic extract of the leaves were prepared and tested against the 
extended-spectrum beta-lactamases-producing K. pneumoniae. The phytochemical screening was performed to 
determine the antibacterial compounds. The guava leaves extracts concentrations ranging from 50 mg/ml – 200 
mg/ml showed active diameter zone of inhibition. The ethanolic extract of guava leaves had minimum inhibition 
concentration and minimum bactericidal concentration of 6.25mg/ml indicating significant antibiotic activity 
against the ESBL isolates. The phytochemical screening of the guava leaves showed the presence of antimicrobial 
phytochemicals such as flavonoids. Ethanolic extracts of guava leaves is proving to be efficacious against multi-
drug resistant ESBL-producing K. pneumoniae, which a major cause urinary tract infections. This offers hope for 
the development of effective antibiotics against multi-drug resistant urinary tract infections due to the presence of 
flavonoids in the guava leaf extracts. Therefore, there is the need to determine the toxicological effect of the active 
antimicrobial compounds isolated in the leaf extracts of guava plant.  
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1.0 Introduction 
Extended-spectrum beta-lactamases (ESBLs) are plasmid-mediated beta lactamases that are capable of 
hydrolysing beta-lactams except carbapenems and cephamycins. They are inhibited by beta-lactamase inhibitors 
such as clavulanic acid, sulbactam and tazobactam. They have been found in the Enterobacteriaceae and other 
Gram negative bacilli. ESBL producing isolates are predominantly Klebsiella pneumoniae and Escherichia coli 
(Paterson and Bonomo, 2005).  
Klebsiella pneumoniae are inhabitants of the intestinal flora and are among the most common causes of 
urinary tract infections such as cystitis (bladder infection) and pyelonephritis (kidney infection). It is estimated 
that about 150 million people develop urinary tract infection in every given year (Flores-Mireles et al., 2015) and 
are more common in women than men (Salvatore et al., 2011).  Enterobacteriaceae are the source of community 
and hospital acquired infections. Because ESBL enzymes are plasmid mediated, the genes encoding these enzymes 
are easily transferable among different bacteria. Most of these plasmids not only contain DNA encoding ESBL 
but also carry genes conferring resistance to several non-beta-lactam antibiotics (Nordmann et al., 2011). 
Consequently, most ESBL isolates are not only resistant to penicillins, cephalosporins and monobactams but also 
to other classes of antibiotics including aminoglycosides, fluoroquinolones, tetracyclines, nitrofurantoin and 
sulfamethoxazole-trimethoprim.  
Since 2000, spread of community acquired enterobacterial isolates (Klebsiella pneumoniae) that produce 
extended-spectrum β-lactamases (ESBLs) capable of hydrolyzing almost all cephalosporins except carbapenems 
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has been reported worldwide (Pitout and Laupland, 2008). Previous studies by Hackman et al. (2013) in Accra 
established that extended-spectrum beta-lactamase (ESBL) producers were increasingly becoming a public health 
nuisance due to community acquired and nosocomial infections.  
Treatment of these multiple drug-resistant organisms has proven to be a therapeutic challenge. ESBL-
producing isolates pose serious public health, financial and logistics challenges because of the limited choice of 
antibiotics for the treatment of infections by ESBL producing isolates. The screening of natural products has been 
the source of innumerable therapeutic agents. Higher plants, as a source for new potential drugs is still largely 
unexplored and only a small percentage of them has been subjected to phytochemical investigation and the 
fractions submitted to pharmacological screening is very low (Saraswathy et al., 2011).  
Guava is mostly cultivated for its fruit and medicinal purposes in the tropical countries. The plant is used for 
the treatment of diarrhea, dysentery, gastroenteritis, hypertension, diabetes, caries and pain relief and for 
improvement in locomotors coordination (Naseer et al., 2018). It contains antioxidants, polyphenols, antiviral 
compounds, anti-inflammatory compounds. Guava leaves also contain many compounds, which act as 
antimicrobial agents (Naseer et al., 2018).  
In this study, the antibacterial activity of ethanolic extract of Psidium guajava leaves was tested against 
ESBL-producing K. pneumoniae. Phytochemical screening of the plants extract was performed to determine the 
various compounds. The study was based on the hypothesis that Psidium guajava will possess phytochemical 
compounds that will have antimicrobial properties against ESBL-bacterial infections through in vitro analysis. 
 
2.0 Methods 
2.1 Study Site 
This research work was carried out at the Centre for Plant Medicine Research, Mampong-Akuapim in the Eastern 
Region of Ghana.  
 
2.2 Sampling of Test Plant Material and Extracts Preparation  
Thousand gram (1000g) of the plant leaves were collected and authenticated at the herbarium at the Centre for 
Scientific Plant Medicine Research (CPMR), Mampong-Akuapim. The sampling was based on the assumption 
that the plant is healthy and uninfected. The plant parts were cut into pieces, air dried at 26 ± 2oC for ten days and 
milled into coarse powder with the aid of an electric blender.  
 
2.3 Ethanolic Extraction, Evaporation and Freeze Drying of Extracts 
Three hundred grams (300g) of the powdered plant part was soaked in 2L of  96% absolute ethanol for 72 hours 
with occasional stirring and was filtered through Wathman’s No.1 filter paper. The filtrate was concentrated with 
the aid of a rotary evaporator and was freeze-dried using the freeze drying machine at a temperature and reduced 
pressure of 35°C and 100-80hPa respectively. The dried extract was stored under refrigeration condition (4oC) 
until needed. 
 
2.4 Reconstitution of Serial Concentrations of the Crude Extract 
Eight hundred milligrams (800mg) of the dried crude extracts were disolved in 4ml of 5% v/v dimethyl sulphoxide 
(DMSO) to prepare 200mg/ml concentration of the leaves extract. Subsequent concentrations of 100, 50, 25, and 
12.5 mg/ml were achieved using the conventional two folds dilution technique. 
 
2.5 Preparation of Muellar Hinton Agar (MHA) as a Culture Media 
The culture media were prepared according to the manufacturers instruction. Thirty eight grams (38g) of the 
powder was suspended in 1000 ml of demineralized water and heated to boil with agitation to completely dissolve 
the powder. The medium was then sterilized by autoclaving at 121 ºC for 15 minutes. 
 
2.6 Detection of ESBL-producing K. pneumoniae using Combined Disc Synergy Method 
MAST IDTM ESßL Detection Discs (Mast Group, UK) were used to screen and confirm the ESBL phenotypes. 
The MAST IDTM ESßL Detection Disks comprise of cefpodoxime 30µg disks, cefpodoxime 30µg + clavulanic 
acid 10µg disks; ceftazidime 30µg disks, ceftazidime 30µg + clavulanic acid 10µg disks and cefotaxime 30µg 
disks, cefotaxime 30µg + clavulanic acid 10µg disks (Paterson and Bonomo, 2005).   
Using a pure culture of the test organism, a suspension in distilled water equivalent in density to a McFarland 
0.5 opacity standard was prepared. Using a sterile swab, the suspension was spread uniformly across the surface 
of Mueller-Hinton agar plate. Using a sterile forceps, one of each MAST IDTM ESßL Detection Disks was placed 
onto the inoculated medium ensuring that they were evenly spaced. The plates were incubated aerobically at 35-
37°C for 18 – 20 hours. The diameter of any zones of inhibition that were observed were measured and recorded.  
The zone of inhibition for the cefpodoxime, ceftazidime and cefotaxime was compared to that of the 
cefpodoxime, ceftazidime and cefotaxime plus clavulanic acid combination disks. An increase in zone diameter 
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of =5mm in the presence of clavulanic acid from any or all of the sets of MAST IDTM ESßL Detection Disks 
indicates the presence of ESBL in the test organism. isolates. 
 
2.7 Subculturing of Extended-spectrum Beta-lactamase Producing K. pneumoniae 
The test organism was subcultured onto Mueller Hinton agar plate and was incubated for 24 hours to obtain a pure 
culture and to ascertain the viability of the organism. At least four colonies from the pure culture were transfer 
into sterile peptone water using an inoculation needle and adjusted to turbidity equivalent to 0.5 McFarland 
Standard. 
 
2.8 Antimicrobial Susceptibility Testing Using Agar Well-Diffusion Method 
Antimicrobial activity of the plant extracts was assessed using the agar- well diffusion method. A 3ml inoculum 
was prepared in peptone water and adjusted to 0.5 McFarland and uniformly spread on the MHA plate using the 
glass spreader. Wells (6mm diameter) were created in the plate using cork borer and 20µl of the plant extract 
concentrations (200 mg/ml – 12.5 mg/ml) were pipetted into the wells at their respective concentration. Amikacin 
(30µg/ml) and colistin (10µg/ml) disks were used as positive controls and 5% v/v DMSO and sterile distilled water 
(SDW) were used as the negative controls. They were allowed to diffuse at room temperature for 30 minutes and 
the plates were then incubated at 37°C for 24 hours.  All experiments were carried out in triplicate. 
After incubation, the diameter zone of inhibition (DZI) were measured and expressed in millimeters. DZI < 
7mm was considered inactive; 7-10 mm partially active; 11-16 active and > 16 very active as described by Junior 
and Zanil (2000).  
 
2.9 Determination of Minimum Inhibition Concentration (MIC) 
Hundred microlitres (100µl) of ethanol extract of the active plants were added to 100 µl of 5% DMSO in the first 
well of the 96-well microplate and mixed well with a micropipette; 100 µl of this dilution was transferred to the 
next well in the column. This two-fold serial dilution was continued to obtain dilutions ranging from101 to 1010 
with the aid of a micropipette. The final volume in each well was 100 µl. Solutions of a reference antibiotic 
amikacin (30µg/ml) and colistin (10 µg/ml) were also serially diluted in different columns of the microplate as a 
positive control. The wells were inoculated with 5µl of microbial suspension of turbidity equivalent to 0.5 
McFarland and incubated at 37ºC for 24 hours. After incubation, 40µl of 0.2mg/ml INT (p-Iodonitrotetrazolium 
violet) dissolved in sterile distilled water was added to each of the wells. The microplates were examined after 
additional 30 to 120 minutes of incubation.  Bacterial growth was indicated by a red colour of INT reduced to the 
formazan. The lowest concentration at which a decreased in the red colour is apparent compared to the next dilution 
was taken as the MIC value.  
 
2.10 Determination of Minimum Bactericidal Concentration (MBC)  
The MBC values were deduced from those wells with lowest concentrations at which no growth took place after 
culture for 24 hours of incubation. A small sample from each of those wells was transferred to fresh nutrient agar 
plates and was incubated overnight at 37ºC and plates were examined for the presence or absence of living 
organisms. Plates with no microbial growth were regarded as the minimum bactericidal concentrations. 
 
2.11 Phytochemical Screening 
Phytochemical screening methods described by Fong et al. (1977) and Ciulei (1982) were used to screen the 
various extracts for the presence of saponins, reducing compounds, polyuronides, phenolic compounds, alkaloids, 
triterpenes, phytosterols, flavonoids and anthracenosides. 
 
3.0 Results 
3.1 Susceptibility of Extended-spectrum Beta-lactamase Producing K. pneumoniae against Ethanolic 
Extract of Psidium guajava   
The ethanolic extract of guava leaves varied zones of inhibition as shown in Table 1: 
Table 1: Susceptibility of Extended-spectrum Beta-lactamase-Producing K. pneumoniae to ethanolic extract of 
Psidium guajava leaves       



























7.0 ± 5.0  
                
Values are mean inhibition zone (mm) ± S.D of three replicates 
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3.2 Minimum Inhibition Concentration (MIC) and Minimum Bactericidal Concentration (MBC) 
The minimum inhibition concentration (MIC) and minimum bactericidal concentration (MBC) shown in Table 2 
were determined using the 96 well microplate. 
Table 2: MIC and MBC of ethanol leaves extracts of Psidium guajava against ESBL-producing K. pneumoniae 
Plant extract MIC (mg/ml) MBC (mg/ml) 
Psidium guajava 6.25 6.25 
 
3.3 Phytochemical Constituents 
The phytochemical constituents of the herbal plant extract were saponins, phenolic compounds, reducing sugars, 
polyuronoids and flavonoids as shown in Table 3. Previous work by Arima and Danno (2002) had isolated the 
antimicrobial compounds in guava and elucidated their chemical structure. 
Table 3: Phytochemical constituents of Psidium guajava leaves 
Phytochemical P. guajava 
Saponins + 
Phenolic compounds + 







            Detected = (+); Not Detected = (-) 
 
4.0 Discussion 
The outcome of this study suggested that ESBL-producing K. pneumoniae are sensitive to varied concentration 
(50 mg/ml – 200 mg/ml) of the ethanolic extracts of guava leaves. More so, the ethanolic leaves extracts of guava 
leaves had MIC and MBC of 6.25mg/ml. This is an indication that the ethanolic extracts of guava leaves have 
significant antibacterial activity against multi-drug resistant K. pneumoniae. This may be because guava leaves 
possess rich phytochemicals such as saponins, phenolic compounds, reducing sugars, polyuronoids and flavonoids. 
Flavonoids have been known to possess the antibacterial effect. According to Arima and Danno (2002), four 
antibacterial compounds were isolated from leaves of guava and these were two new flavonoid glycosides: morin-
3-O-alpha-L-lyxopyranoside and morin-3-O-alpha-L-arabopyranoside and guaijavarin and quercetin. The plant 
extract used in this study may contain these four compounds since they fall under flavonoids and the phytochemical 
screening of the test plant revealed that it contains flavonoids as shown in Table 1.  
The activity of the standards (amikacin and colistin) used in this study as positive control corresponds with 
the results of Hackman et al. (2017) although amikacin (30 µg/ml) used in this study shows a higher diameter zone 
of inhibition. According to Junior and Zanil (2000) diameter zone of inhibition of 11-16 is considered active 
and >16 is considered very active. From the results, concentrations of the test plant ranging from 50 mg/ml – 200 
mg/ml showed active diameter zone of inhibition. From Table 2, P. guajava had an MIC of 6.25mg/ml with MBC 
of 6.25mg/ml with percentage inhibition index of 13.33. This showed that at those concentrations P. guajava is 
able to inhibit the growth of the ESBL-producing K. pneumoniae. 
 
5.0 Conclusions 
The hypothesis for this study proved positive since the plant under study showed activity against the ESBL-
producing K. pneumoniae. Ethanolic extracts of guava leaves is proving to be efficacious against multi-drug 
resistant ESBL-producing K. pneumoniae, which a major cause urinary tract infections. Phytochemical screening 
of the leaves showed that it possesses saponins, phenolic compounds, reducing sugars, polyuronoids and 
flavonoids. The flavonoids such as morin-3-O-alpha-L-lyxopyranoside, morin-3-O-alpha-L-arabopyranoside, 
guaijavarin and quercetin are known to be responsible for the antibacterial efficacy of the guava leaves extracts. 
This offers hope for the development of effective antibiotics for the treatment of multi-drug resistant urinary tract 
infections. Therefore, there is the need to determine the toxicological effect of the active antimicrobial compounds 
isolated in the leaf extracts of guava plant.  
 
Abbreviations 
CPMR: Centre for Plant Medicine Research 
DMSO: Dimethyl Sulphoxide 
DZI: Diameter Zone of Inhibition  
K. pneumoniae: Klebsiella pneumoniae 
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ESBL: Extended-spectrum beta-lactamase 
INT: p-Iodonitrotetrazolium violet 
MIC: Minimum Inhibitory Concentration 
MBC: Minimum Bactericidal Concentration 
MHA: Mueller Hinton Agar 
P. guajava: Psidium guajava 
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